The U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc's intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator's website...
Centrum marks its entry in India under Haleon (erstwhile GlaxoSmithKline Consumer Healthcare). The company announced the launch of Centrum Multivitamin range recognising the difference in nutritional requirements by gender and age in India and...
Aragen Life Sciences Private Limited announced that it has entered into an agreement with UK-based firm, NeoVac, for manufacturing a lipid product that will support the development of lipid nanoparticles (LNP) for use in developing RNA vaccines...
The Tata Memorial Hospital (TMH) operating model will be replicated by the Kalyan Singh Super Specialty Cancer Institute (KSSSCI) in Mumbai. The effort is to learn the TMH model of functioning so that it can be replicated at KSSSCI. The director a...
Since the COVID-19 pandemic first impacted the life science industry around the world, Pharmaceutical R&D spending has reached over $200 billion each year — and it’s projected to surpass $250 billion by 2026. Rising expenditure patterns indicate
Modern drug discovery heavily relies on predictive analysis, artificial intelligence and machine learning. In order to boost innovation in drug discovery, a lot of big pharma and biotech businesses are turning to data science. Utilization of data ana
Information Security is a critical requirement in the Bank¬ing and Healthcare industry. News abounds about data theft and breaches affecting millions of customers. With increasing threat vectors and rising intensity of attacks it is im¬portant that w
Healthcare is one of the fast¬est growing sectors in India and it is relatively offering a lower priced treatment options that provide a great opportunity for the growth of various segments across the industry – medical devices, pharmaceutical manuf
As of today, around 70 percent of critical Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) are imported. The PLlscheme is meant for promotion of domestic manufacturing of critical KSMs, Drug intermediates and APIs in India
The last year has been a whirl¬wind for the entire world, courtesy of the COVID-19 pan¬demic. With markets plummeting, businesses shutting down and indi¬viduals scampering to keep them¬selves safe, there has been a drastic change in industries
, CDSCO.jpg)
